Literature DB >> 10947246

Reduction of syndecan-1 expression is associated with dysplastic oral epithelium.

T Soukka1, J Pohjola, P Inki, R P Happonen.   

Abstract

Syndecans are a family of integral membrane proteoglycans that participate in cell-matrix interactions and growth factor binding. Syndecan-1 expression is induced during keratinocyte differentiation and reduced in squamous cell carcinomas. The purpose of this study was to examine the alteration in syndecan-1 expression in dysplastic oral epithelium. Sixty-six oral biopsy specimens (43 epithelial dysplasias, 3 carcinoma in situ and 20 squamous cell carcinomas) were studied using immunohistochemical methods. The normal epithelium specimens were highly positive for syndecan-1. Fifteen of 46 dysplasias or carcinoma in situ specimens showed negative or weak staining for syndecan-1, two of which were totally negative. Intermediate and strong staining were observed in 17 and 14 dysplasias or carcinoma in situ specimens, respectively. Thirteen (65%) squamous cell carcinomas showed negative or weak staining for syndecan-1, seven of which were totally negative. Only three carcinomas had a strong syndecan-1 expression. Four of the 34 patients with dysplasia who were followed up developed squamous cell carcinoma. All these dysplasias had weak or totally negative syndecan-1 expression. The results suggest that the loss of syndecan-1 is associated with dysplastic changes in oral epithelium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947246     DOI: 10.1034/j.1600-0714.2000.290704.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  11 in total

1.  The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma.

Authors:  Hyunjin Kim; Dong Soon Choi; Suk-Joon Chang; Jae Ho Han; Churl K Min; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

Review 2.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

Review 3.  New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.

Authors:  Innoc Han; Haein Park; Eok-Soo Oh
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

4.  Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach.

Authors:  Yanfei Wang; Xiaoping Ao; Huy Vuong; Meghana Konanur; Fred R Miller; Steve Goodison; David M Lubman
Journal:  J Proteome Res       Date:  2008-08-27       Impact factor: 4.466

Review 5.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

Review 6.  Syndecans in tumor cell adhesion and signaling.

Authors:  DeannaLee M Beauvais; Alan C Rapraeger
Journal:  Reprod Biol Endocrinol       Date:  2004-01-07       Impact factor: 5.211

7.  Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.

Authors:  Anna Farnedi; Silvia Rossi; Nicoletta Bertani; Mariolina Gulli; Enrico Maria Silini; Maria Teresa Mucignat; Tito Poli; Enrico Sesenna; Davide Lanfranco; Lucio Montebugnoli; Elisa Leonardi; Claudio Marchetti; Renato Cocchi; Andrea Ambrosini-Spaltro; Maria Pia Foschini; Roberto Perris
Journal:  BMC Cancer       Date:  2015-05-03       Impact factor: 4.430

8.  Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis.

Authors:  Sushant S Kamat; G S Kumar; Ajit V Koshy
Journal:  Dent Res J (Isfahan)       Date:  2013-05

9.  Detection of Micro-invasion in Sudanese Oral Verrucous Carcinoma Samples Using Syndecan-1 Stain.

Authors:  Akb Elhassan; A M Suleiman; Nia El Dawi; Sofia B Mohamed
Journal:  Biomark Cancer       Date:  2019-09-16

Review 10.  Syndecans as modulators and potential pharmacological targets in cancer progression.

Authors:  Despoina Barbouri; Nikolaos Afratis; Chrisostomi Gialeli; Demitrios H Vynios; Achilleas D Theocharis; Nikos K Karamanos
Journal:  Front Oncol       Date:  2014-02-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.